Author: Ned Douthat

“Now, for a long time botox, made by Allergan, a stock you know we like, has been synonymous with smooth skin. But now Medicis we’ve likened, MRX as the Pepsi to Allergan’s Coke, has come out with a new...

At Ockham, we prefer to analyze the markets from a fundamental perspective, but we are not so proud as to think that nothing can be gained by looking at the technical perspective from time to time.  One well known...

The world’s second largest soft drink maker, PepsiCo. (PEP), announced a share repurchase program that could amount to $15 billion over the next three years.  The company had suspended buy backs earlier this year in...

After more than a year of bidding Terra Industries (TRA) has finally agreed to combine with CF Industries (CF).   The long, drawn out bidding process involved another potential suitor, but yesterday Yara International...

Imax Corp. (IMAX), which operates giant screened movie theatres as well as licenses the technologies to third parties, reported an outstanding fiscal fourth quarter 2009 on Thursday morning.  The company benefited from the...

Allergan Inc (AGN) received approval from the FDA on Tuesday for a Botox treatment of stiffness in elbows, wrists and fingers in adults, a condition known as spasticity.  There is a significant market potential for this...

“…Now, after that is Exxon, off 2.1% since the year began. This petro-giant is totally problematic. No great yield. Nothing new until the XTO, that natural gas deal closes and it hasn’t budged as oil has run...